Evidence map›Paper›PMID 30686765›Full record

ArticleCell stem cell2019

Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.

Laura Lukjanenko, Sonia Karaz, Pascal Stuelsatz, Uxia Gurriaran-Rodriguez, Joris Michaud, Gabriele Dammone, Federico Sizzano, Omid Mashinchian, Sara Ancel, Eugenia Migliavacca and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 217 papers.

0numbers the graph read from it
0cells of the map it votes in
217citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

217 citing papers in PubMed, 352 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

157 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 3 countries.

Laura LukjanenkoNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Sonia KarazNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Pascal StuelsatzNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Uxia Gurriaran-RodriguezSprott Center for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Joris MichaudNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Gabriele DammoneNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Federico SizzanoNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Omid MashinchianNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Sara AncelNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Eugenia MigliavaccaNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Sophie LiotInstitut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS 5310, INSERM U1217, Lyon, France.
Guillaume JacotNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Sylviane MetaironNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Frederic RaymondNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Patrick DescombesNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Alessio PaliniNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland.
Benedicte ChazaudInstitut NeuroMyoGène, Université Claude Bernard Lyon 1, CNRS 5310, INSERM U1217, Lyon, France.
Michael A RudnickiSprott Center for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
C Florian BentzingerNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; Département de pharmacologie et physiologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
Jerome N FeigeNestlé Research, EPFL Innovation Park, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), 1015 Lausanne, Switzerland. Electronic address: jerome.feige@rd.nestle.com.
École Polytechnique Fédérale de Lausanne · CHNestlé (Switzerland) · CHOttawa Hospital · CAInserm · FRInstitut NeuroMyoGène · FRUniversité de Sherbrooke · CA

Funding

GENETIC REGULATION OF SKELETAL MUSCLE REPAIRR01AR044031 · NIAMS · OTTAWA HOSPITAL RESEARCH INSTITUTE · PI RUDNICKI, MICHAEL A · 1996 to 2025
$5.6M
CIHR FDN-148387NIAMS NIH HHS R01 AR044031
6 · The paper itself

Abstract

Research on age-related regenerative failure of skeletal muscle has extensively focused on the phenotypes of muscle stem cells (MuSCs). In contrast, the impact of aging on regulatory cells in the MuSC niche remains largely unexplored. Here, we demonstrate that aging impairs the function of mouse fibro-adipogenic progenitors (FAPs) and thereby indirectly affects the myogenic potential of MuSCs. Using transcriptomic profiling, we identify WNT1 Inducible Signaling Pathway Protein 1 (WISP1) as a FAP-derived matricellular signal that is lost during aging. WISP1 is required for efficient muscle regeneration and controls the expansion and asymmetric commitment of MuSCs through Akt signaling. Transplantation of young FAPs or systemic treatment with WISP1 restores the myogenic capacity of MuSCs in aged mice and rescues skeletal muscle regeneration. Our work establishes that loss of WISP1 from FAPs contributes to MuSC dysfunction in aged skeletal muscles and demonstrates that this mechanism can be targeted to rejuvenate myogenesis.

Indexed as

AdipocytesAdipogenesisAgingAnimalsCCN Intercellular Signaling ProteinsCells, CulturedHumansMiceMice, Inbred C57BLMice, KnockoutMuscle, SkeletalProto-Oncogene ProteinsStem CellsCCN4 protein, humanCCN4 protein, mouseCCN Intercellular Signaling ProteinsProto-Oncogene ProteinsagingCCN4fibro-adipogenic progenitorsmatricellular signalingmuscle stem cellsregenerationsatellite cellskeletal musclestem cell nicheWISP1

Identifiers

PMID30686765
PMCPMC6408230
OpenAlexW2912606098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.